Welcome to ImmunGene, Inc.
Next generation targeted protein therapeutics
ImmunGene, Inc. is a privately held drug discovery and development company, developing next generation of monoclonal antibody-based therapeutics to treat cancer, autoimmune creating disorders and other diseases.
We are leveraging promising science to tap the power of the immune systems to develop therapeutic antibodies that are highly optimized for efficacy and a superior safety profile.
Our technology allows us to fuse cytotoxic cytokines to antibodies to selectively target disease causing cells and tissues while reducing the systemic toxicity of the cytokines.
We are working to make novel drug candidates for treating diseases that affect tens of millions of people worldwide. Our primary focus is on safe and effective treatments for cancer.
We also have programs underway to treat other potentially devastating diseases, including infections.